CAR-NK

Unknown Manufacturer

Generate AI report

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

PRIMARY NK CAR CONSTRUCTS AND METHODS
EP 4491235 A3Applicant: IMMUNITYBIO INCPriority: 2019
CN
EP
US
WO
8 publications
ELIMINATION OF CD19-POSITIVE LYMPHOID MALIGNANCIES BY CD19-CAR EXPRESSING NK CELLS
EP 3743512 A4Applicant: NANTKWEST INCPriority: 2018
CN
EP
US
8 publications
TARGETING LILRB4 WITH CAR-T OR CAR-NK CELLS IN THE TREATMENT OF CANCER
EP 3707165 A4Applicant: UNIV TEXASPriority: 2017
CN
EP
US
WO
6 publications
TISSUE FACTOR-TARGETING CAR-NK AND CAR-T CELL THERAPY
EP 3687555 A4Applicant: OHIO STATE INNOVATION FOUNDATIONPriority: 2017
CN
EP
US
WO
5 publications
LARGE-SCALE COMBINED CAR TRANSDUCTION AND CRISPR GENE EDITING OF NK CELLS
EP 4065140 A4Applicant: UNIV TEXASPriority: 2019
CN
EP
US
WO
4 publications
CHIMERIC ANTIGEN RECEPTOR (CAR) NK CELLS AND USES THEREOF
EP 4232560 A4Applicant: RES INST NATIONWIDE CHILDRENS HOSPITALPriority: 2020
CN
EP
US
WO
4 publications
CHIMERIC ANTIGEN RECEPTOR (CAR) CONSTRUCTS WITH NK RECEPTOR SIGNALING DOMAIN
EP 4519306 A4Applicant: H LEE MOFFITT CANCER CENTER & RESEARCH INST INCPriority: 2022
CN
EP
US
WO
4 publications
CXCR3 OVEREXPRESSION IN CAR-NK CELLS PRIMES MIGRATION/HOMING INTO THE TUMOR MICROENVIRONMENT
EP 4522184 A4Applicant: DANA FARBER CANCER INST INCPriority: 2022
CN
EP
US
WO
4 publications
PURIFYING TCR-MODIFIED T CELLS USING TCR-SPECIFIC CAR-NK CELLS
EP 4601677 A1Applicant: UNIV BERLIN CHARITEPriority: 2022
EP
US
WO
4 publications
MUTATED PD1 ECTODOMAIN FRAGMENT AND CAR CONTAINING SAME, AND NK CELL
EP 4653455 A1Applicant: METTA THERAPEUTICS CO LTDPriority: 2023
CN
EP
WO
4 publications

Drugs